drugset / Trial / NCT06915792

PEACE Trial: Postpartum Evaluation of Antihypertensive Cessation and Efficacy

NCT06915792

Phase 4 Recruiting 110 enrolled University of California, Los Angeles
RandomizedParallel-groupOpen-labelTreatment

Summary

This randomized controlled trial compares two common medications, labetalol and extended-release nifedipine, to determine which is more effective at managing postpartum high blood pressure. We hypothesize that extended-release nifedipine will better control blood pressure and reduce the need for continued medication beyond six weeks postpartum. The study will enroll 110 postpartum participants, randomly assigning them to one of the two medications, with remote blood pressure monitoring to evaluate treatment effectiveness and inform postpartum hypertension management.

Timeline

Start
2025-06-01
Primary completion
2027-07-31
Completion
2027-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Labetalol Small molecule 200 mg Oral
Subject Nifedipine Other / unclassified 30 mg Oral